相关实验视频

Updated: May 6, 2026

A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

A Rapid and Chemical-free Hemoglobin Assay with Photothermal Angular Light Scattering

Published on: December 7, 2016

血红蛋白缺陷查中的新兴技术和先进策略

Cindy Zhang¹, Victoria Crystal Chen², Bremansu Osa-Andrews³

¹School of Engineering and Computer Science, University of Texas Dallas, Richardson, TX 75080, USA.

Journal of clinical medicine

|August 28, 2025

概括

在初级保健中对血红蛋白病,遗传性血液疾病进行查对于早期诊断和改善患者的结果至关重要. 在全球范围内,定制的查策略至关重要,以满足不同需求并促进人口健康.

科学领域:

血液学
遗传学
公共卫生

背景情况:

血球蛋白病是普遍存在的遗传性疾病,导致全球显著的死亡率和发病率.
初级保健查对于早期发现,治疗和生殖决策至关重要.

研究的目的:

在初级保健机构审查血红蛋白缺陷的实际查技术.
考虑到区域因素和全球移民,讨论不断发展的查策略.

主要方法:

对高性能液态染色学 (HPLC) 的最新进展进行了回顾.
毛细管区域电泳 (CZE),质谱测试 (MS) 和临床检测 (POCT) 的评估.
包括分子方法和区域选方法.

主要成果:

各种先进的技术提高了血红蛋白病查的准确性和可访问性.
区域战略强调需要具体的,具有成本效益和公平的方法.
全球移民需要灵活适应的查框架.

结论:

有效的初级护理对血红蛋白病的查改善了患者的结果和人口的健康.
为了应对这些遗传性疾病的全球性负担, 必须采用量身定制且易于使用的查方法.
需要不断调整查策略以满足不断变化的医疗保健需求和人口动态.

关键词:

没有血血红蛋白缺陷护理点测试状细胞疾病沙拉西米亚

更多相关视频

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Magnetic Levitation Coupled with Portable Imaging and Analysis for Disease Diagnostics

Published on: February 19, 2017

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy

相关概念视频

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...